1. Home
  2. NWGL vs CVKD Comparison

NWGL vs CVKD Comparison

Compare NWGL & CVKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NWGL
  • CVKD
  • Stock Information
  • Founded
  • NWGL 2008
  • CVKD 2022
  • Country
  • NWGL Macau
  • CVKD United States
  • Employees
  • NWGL N/A
  • CVKD N/A
  • Industry
  • NWGL
  • CVKD Medicinal Chemicals and Botanical Products
  • Sector
  • NWGL
  • CVKD Health Care
  • Exchange
  • NWGL Nasdaq
  • CVKD Nasdaq
  • Market Cap
  • NWGL 26.2M
  • CVKD 29.5M
  • IPO Year
  • NWGL 2023
  • CVKD 2023
  • Fundamental
  • Price
  • NWGL $1.02
  • CVKD $11.92
  • Analyst Decision
  • NWGL
  • CVKD Strong Buy
  • Analyst Count
  • NWGL 0
  • CVKD 1
  • Target Price
  • NWGL N/A
  • CVKD $32.00
  • AVG Volume (30 Days)
  • NWGL 764.7K
  • CVKD 35.1K
  • Earning Date
  • NWGL 07-29-2025
  • CVKD 08-06-2025
  • Dividend Yield
  • NWGL N/A
  • CVKD N/A
  • EPS Growth
  • NWGL N/A
  • CVKD N/A
  • EPS
  • NWGL N/A
  • CVKD N/A
  • Revenue
  • NWGL $21,539,347.00
  • CVKD N/A
  • Revenue This Year
  • NWGL N/A
  • CVKD N/A
  • Revenue Next Year
  • NWGL N/A
  • CVKD N/A
  • P/E Ratio
  • NWGL N/A
  • CVKD N/A
  • Revenue Growth
  • NWGL N/A
  • CVKD N/A
  • 52 Week Low
  • NWGL $0.91
  • CVKD $5.70
  • 52 Week High
  • NWGL $6.61
  • CVKD $22.90
  • Technical
  • Relative Strength Index (RSI)
  • NWGL 44.65
  • CVKD 36.41
  • Support Level
  • NWGL $0.99
  • CVKD $11.15
  • Resistance Level
  • NWGL $1.07
  • CVKD $13.63
  • Average True Range (ATR)
  • NWGL 0.07
  • CVKD 0.99
  • MACD
  • NWGL -0.01
  • CVKD 0.01
  • Stochastic Oscillator
  • NWGL 33.33
  • CVKD 29.49

About NWGL Nature Wood Group Limited

Nature Wood Group Ltd is a vertically-integrated forestry company that focuses on FSC business operations. It produces various products, including logs, decking, flooring, sawn timber, recycled charcoal, synthesized charcoal, machine-made charcoal, and essential oils. The Group owns natural forest concessions and cutting rights for exploiting timbers on parcels of land in Peru. The Group is organized into two operating divisions; Direct Purchase and Original Design Manufacturer (ODM) Services, and Manufacturing segments. The Direct Purchase and ODM Segment that derives the majority of revenue engages in the business of sourcing live wood and owning designed designs on wood products for sales to end customers. Geographically, the company generates a majority of its revenue from China.

About CVKD Cadrenal Therapeutics Inc.

Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.

Share on Social Networks: